The Clorox Company $CLX Holdings Raised by CIBC Asset Management Inc

CIBC Asset Management Inc grew its stake in shares of The Clorox Company (NYSE:CLX) by 57.2% in the 4th quarter, HoldingsChannel reports. The firm owned 31,227 shares of the company’s stock after acquiring an additional 11,360 shares during the quarter. CIBC Asset Management Inc’s holdings in Clorox were worth $3,149,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of CLX. Norges Bank purchased a new stake in shares of Clorox during the fourth quarter valued at $135,735,000. Van ECK Associates Corp lifted its holdings in shares of Clorox by 93.9% during the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Clorox by 23.1% during the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after purchasing an additional 750,415 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Clorox by 6,907.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after buying an additional 739,005 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new position in Clorox during the second quarter valued at $71,856,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent analyst reports. TD Cowen upped their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. Morgan Stanley dropped their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, JPMorgan Chase & Co. dropped their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $103.40.

Clorox Stock Down 0.1%

CLX stock opened at $94.07 on Monday. The firm has a market cap of $11.37 billion, a PE ratio of 15.27, a PEG ratio of 0.49 and a beta of 0.56. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The company has a fifty day simple moving average of $96.95 and a 200 day simple moving average of $105.34. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the business posted $1.45 earnings per share. The business’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts anticipate that The Clorox Company will post 5.61 EPS for the current fiscal year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.